acrobat

   Acrobat Reader is required to view our Press Releases. If you do not already have it, please click the icon to download it.
TORONTO, ON – March 10, 2017 – SCiAN Services, Inc., a North American Biostatistics & Data Management CRO for 30 years is pleased to announce the approval of a new operations structure by the Board of Directors. Under this mandate, 2 primary divisions have been created: • Biostatistics & Data Management • Clinical Data Systems (EDCpro family of products).
In recognizing the sponsors on their accomplishment, Dr. Miklos Schulz, President and CEO of SCiAN Services, Inc. said: “We also want to thank Biotie Therapies, PDC Biotech, and Astellas Global for the opportunity of being part of their clinical development program and extend our continuous commitment to supporting their innovative programs. The professional team at SCiAN shares their excitement in having been an integral part and contributor of best-in-class trial design, data management and biostatistics.”
Key to this clinical development collaboration is our ability to extend preferred pricing to Angiochem, which results from greater efficiencies accrued through multiple trials run on the same eClinical platform, EDCpro
New Job Opportunities at SCiAN: Biostatisticians - Clinical Data Managers - CRAs
TORONTO, ON – November 18, 2013 – SCiAN Services, Inc., a data management and biostatistics CRO for 27 years and EDC developer announces that St. Clare Chung will co-present at the Outsourcing in Clinical Trials Conference in Toronto on the case study: "Developing an alternative outsourcing model to harness data quality and integrity ". The presentation will take place on Wednesday, November 20, 2013 at 10:45 am Eastern Time. Dr. Miklos Schulz, President and CEO of SCiAN Services, will follow as a panelist at 10:45 on the topic of: “Spearheading your selection process through a change in RFP and bid defence by discussion of best practice ideas currently conducted by companies”.
TORONTO, ON – February 12, 2013 – SCiAN Services, Inc., a North American Clinical Data Management - Biostatistics CRO and EDC solution provider announces that Adaptimmune has selected SCiAN’s EDCPRO platform to manage its clinical trials starting in 2013. Following a review of several EDC vendors and CROs a services agreement was executed with SCiAN to deliver a comprehensive systems and services solution for Web-based data capture and data management, including pharmacovigilance using the SAEPRO module and integrated electronic record management of trial master files (TMF) using the EDMS extension.
At this stage of the clinical trial, the Sponsor has initiated sites, patients are being screened, enrolled, randomized and treated. The CTM and CDM group are completing their tasks smoothly. When things are running smoothly, no thoughts are given to fine-tuning the system to how users interpret the protocol or how the system is used across different sites. Then comes the dreaded protocol amendment which may change everything that has been established: (i) inclusion/exclusion criteria, (ii) study assessments, (iii) treatment group assignment, (iv) interim analyses, to name a few. In this 3rd of 4 webinars, we look at the impact of one or more protocol amendment(s) on the study database and the EDC team and how changes can be implemented smoothly and with minimal effect on the ongoing study.
Webinar-Advanced Electronic Data Capture (EDC) Trials August 22, 2012 at 12:00 PM - 1:00 PM Most EDC trials rely on separate CDM systems and processes to perform many of the routine clinical data management tasks off-line in an awkward batch process rendering the overall solution slow, error-prone and expensive. We will explore the reasons behind this phenomenon and possible solutions to bring most of the CDM function under the EDC umbrella with the net result of increased overall efficiencies, shorter timelines, reduced cost for like data quality.
Advanced EDC Trials - Bringing the Team Together (Webinar Session #2) Having screened and selected the outsourced service partners the Sponsor shifts gears to kicking-off the clinical trial. The key challenge typically faced by Biotech/Biopharma drug developers is how to organize these unique ad hoc groups / service providers into working together as a cohesive team. The CDM/STAT group's role as the intermediary with the rest of the team supported by the functionality of a robust EDC system are critical factors for bringing the team together and setting up the clinical study for success. In this 2nd of 4 webinars, St. Clare Chung highlights the typical problems associated with the initial stage and presents several tips and solutions to addressing them at the start, while showing how technology can play an integral part in coordination, control and communication.
At the core of conducting a successful clinical trial is how you collect and manage your data. The primary need of Biotech/Biopharma companies is consistent and scientifically/medically credible data delivered on time and on budget, one study at a time; under the constant challenge of significant "mid-study" protocol and database changes. In this 1st of 4 webinars, Ann Neale and St. Clare Chung will start the discussion by providing insight into the unique needs of Biotech/Biopharma companies from both the Sponsor and Technology/Services providers (CROs) perspectives. Subsequent webinars will focus on case studies, specific challenges and solutions.
TORONTO, ON – March 12, 2012 – SCiAN Services, Inc., an EDC solution provider for 15 years and CRO announces that Christine Watters and St. Clare Chung will present at the Outsourcing in Clinical Trials Conference in Philadelphia on the topic: "Making EDC part of your quality control team through intelligent system implementation". The presentation will take place on Wednesday, March 26, 2012 at 12:00, Eastern Time.
TORONTO, ON – March 1, 2012 – SCiAN Services, Inc., an EDC solution provider for 15 years and CRO announces that St. Clare Chung will present at the End-to-End Clinical Data Management Conference in Philadelphia on the topic: "Realizing the original promise of EDC: Achieving quality data on time in Phase II-III studies". The presentation will take place on Wednesday, March 21, 2012 at 10:00, Eastern Time.
TORONTO, ON – February 29, 2012 – SCiAN Services, Inc., an EDC solution provider for 15 years and CRO will be exhibiting at the Partnerships in Clinical Trials conference. Come by our both # 532, as we publicly unveil EDCPRO version 4.0 for the first time. Some of the unique new capabilities of this advanced e-clinical system include: protocol consistency alerts; guided data entry; eCRF navigation in a unified interface and much more.
“Fully configured EDC Study Databases on a Monthly Subscription Basis"
"Developing accurate cost estimates to stay within tight budget constraints through your study's lifecycle"
TORONTO, ON – October 24, 2011 – SciAn Services, Inc., an EDC solution provider for 15 years and CRO is pleased to announce the launch of its monthly subscription EDC data management solution. Biotech, pharmaceutical companies and academic research groups have been asking for more cost-effective options in managing their clinical study data. The availability of SciAn’s database libraries and Software-as-a-Service (SaaS) technology now delivers on that demand without any startup costs and on a month-by-month fee basis for the duration of the clinical trial, in a ground-breaking new way of running clinical studies.
TORONTO, ON – April 4th, 2011 – SciAn Services Inc., a Contract Research Organization (CRO) providing clinical research services as well as electronic data capture (EDC) and serious advent (SAE) software to pharmaceutical and biotech companies confirmed today the Company’s attendance at the Bio 2011 International.
TORONTO, ON – January 28th, 2011 – SciAn Services Inc., a Contract Research Organization (CRO) providing clinical research services and electronic data capture (EDC) software to biotech companies relaunched its serious adverse event (SAE) reporting software known as “SAE pro” that enables biotech companies to comply with the safety reporting requirements of 21 CFR Parts 312 & 320 set forth by the FDA.
TORONTO, ON – November 1st, 2010 – SciAn Services, Inc., a Contract Research Organization (CRO) servicing biotech companies in all phases of clinical studies announced today the opening of another US office. The location of the second office is in Walnut Creek, near San Francisco, California.
TORONTO, ON – October 5th, 2010 – SciAn Services, Inc., a Contract Research Organization (CRO) servicing biotech companies in all phases of clinical studies confirmed today the company’s attendance at Biotech 2010 in Pennsylvania, Philadelphia. The Biotech 2010 conference will be held at the Pennsylvania Convention centre from October 27th to October 28th.
TORONTO, ON – August 10th, 2010 – SciAn Services Inc., a Contract Research Organization (CRO) servicing biotech companies in all phases of clinical studies announced today the release of edcpro version 4.0 – the company’s proprietary electronic data capture (EDC) system in the fall of 2010.
TORONTO, ON – July 20th, 2010 – SciAn Services, Inc. a Contract Research Organization (CRO) servicing biotech companies in all phases of clinical studies, announced today that the company’s proprietary electronic data capture (EDC) system - edcpro now supports mobile access to data via Apple’s iPad. This enables researchers to view remotely SciAn’s eCRFs, reports and other tools for clinical trial data management in the same graphical formats as seen on a desktop computer.
TORONTO, ON – May 15th, 2010 – SciAn Services, Inc. a Contract Research Organization (CRO) servicing biotech companies in all phases of clinical studies, announced today that St. Clare Chung, Vice-President of Biostatistics and CDM will be speaking on “Planning and Executing Global Trials” at the 2010 MAGI Clinical Research East conference in collaboration with fellow panelist, W. Christopher Fang, Worldwide Director, Clinical Affairs at Johnson & Johnson.
Toronto, Ontario, Canada, May 1st, 2010 – SciAn Services, Inc., a Canadian Biotech CRO is pleased to confirm their attendance at the 2010 Bio International Convention in Chicago. This is the fifth consecutive year SciAn Services has been invited by the International Trade Branch, Ministry of Economic Trade and Development to exhibit under the Ontario government’s pavilion.
TORONTO, ON – April 11th, 2010 – SciAn Services, Inc. a Contract Research Organization (CRO) servicing biotech companies in all phases of clinical studies announced today the addition of IVRS functionality: a new online blinded randomization and study drug management module to the Company’s edcpro.
TORONTO, ON – February 17th, 2010 – SciAn Services, Inc. a contract research organization (CRO) servicing biotech companies in all phases of clinical studies, announced today that St. Clare Chung, Vice-President of Operations will be speaking on “Lessons Learned and Conquering Operational Challenges When Conducting Multi- Regional Clinical Trials” at the 4th Annual Global Clinical Trial Partnerships in collaboration with fellow panelists, David Facklam, Senior Director, Global Development Operations of Astellas Pharma Global Development and Dr. John Strony, Section Head Thrombosis/Cardiovascular of Merck Research Laboratory.
TORONTO, ON – January 14th, 2010 – SciAn Services, a contract research organization (CRO) providing EDC and statistical analysis services to biotech companies in all phases of clinical studies, announced today the company’s attendance at “The 12th annual BioCEO & Investor Conference” in Waldorf-Astoria, New York City.
TORONTO, ON - October 01st, 2009 – SciAn Services, Inc., a contract research organization (CRO) servicing biotech companies in all phases of clinical studies, announced today the opening of a US office in King of Prussia, Pennslyvania.
TORONTO, ON - September 30th, 2009 – SciAn Services, Inc. a Contract Research Organization (CRO) servicing biotech companies in all phases of clinical studies, announced today that Dr. Miklos Schulz, PhD., will be presenting on “Selecting the Right Biotech CRO: A Potential Investment Multiplier”. The successful clinical study that completes within budget and complies with strict timelines relies heavily on the people, processes and systems. Through Dr. Schulz’ more than 25 years of industry experience, the presentation will reveal key factors to consider during the selection process for a CRO. The resulting check list is intended as a helpful guideline for choosing the right CRO; thereby, setting the clinical study up for success.
Toronto, Ontario, Canada, April 30, 2009 – SciAn Services, Inc., a Canadian Biotech CRO is pleased to confirm its attendance at Bio 2009 in Atlanta. This is the fourth consecutive year SciAn Services has been invited by the International Trade Branch, Ministry of Economic Trade and Development, to exhibit within the Ontario government’s pavilion.